Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

74.51
-0.6400-0.85%
Post-market: 73.90-0.6100-0.82%18:20 EST
Volume:2.33M
Turnover:174.22M
Market Cap:14.36B
PE:-17.81
High:75.61
Open:74.96
Low:73.95
Close:75.15
52wk High:75.61
52wk Low:25.34
Shares:192.71M
Float Shares:151.20M
Volume Ratio:1.41
T/O Rate:1.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1844
EPS(LYR):-2.8793
ROE:-1789.67%
ROA:-43.47%
PB:-7.43
PE(LYR):-25.88

Loading ...

Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Feb 22, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 18, 2024

Major Issues Report

Form 8-K - Current report
Jan 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 09, 2024

Major Issues Report

Form 8-K - Current report
Jan 06, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 27, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]